Positron Emission Tomography Scan and CT Scan in Planning Radiation Therapy for Patients With Stage II or Stage III Non-Small Cell Lung Cancer
Lung Cancer
About this trial
This is an interventional diagnostic trial for Lung Cancer focused on measuring stage II non-small cell lung cancer, stage IIIA non-small cell lung cancer, stage IIIB non-small cell lung cancer, recurrent non-small cell lung cancer
Eligibility Criteria
DISEASE CHARACTERISTICS: Histologically or cytologically confirmed non-small cell lung cancer (NSCLC) Stage IIA/IIB or stage IIIA/IIIB disease Planning to undergo radiotherapy Local or regional nodal recurrence after surgery allowed No malignant pleural effusion PATIENT CHARACTERISTICS: Zubrod performance status 0-2 Negative pregnancy test Not pregnant or nursing Fertile patients must use effective contraception PRIOR CONCURRENT THERAPY: See Disease Characteristics Concurrent neoadjuvant and/or concurrent chemotherapy allowed No concurrent intensity-modulated radiotherapy
Sites / Locations
- Siteman Cancer Center at Barnes-Jewish St. Peters Hospital - Saint Louis
- Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
- University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
- McGill Cancer Centre at McGill University
Arms of the Study
Arm 1
Experimental
Arm 1
Two radiation oncologists are randomly assigned to develop either a 3DCRT plan using CT only, or a 3DCRT plan using fused PET/CT